C-peptide determination in the diagnosis of type of diabetes and its management: A clinical perspective.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- C-peptide determination in the diagnosis of type of diabetes and its management: A clinical perspective.
- Published In:
- Diabetes, obesity & metabolism, 24(10), 1912-1926 (2022)
- Authors:
- Maddaloni, Ernesto, Bolli, Geremia B, Frier, Brian M, Little, Randie R, Leslie, Richard D, Pozzilli, Paolo, Buzzetti, Raffaela
- Database ID:
- RPEP-06342
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-06342APA
Maddaloni, Ernesto; Bolli, Geremia B; Frier, Brian M; Little, Randie R; Leslie, Richard D; Pozzilli, Paolo; Buzzetti, Raffaela. (2022). C-peptide determination in the diagnosis of type of diabetes and its management: A clinical perspective.. Diabetes, obesity & metabolism, 24(10), 1912-1926. https://doi.org/10.1111/dom.14785
MLA
Maddaloni, Ernesto, et al. "C-peptide determination in the diagnosis of type of diabetes and its management: A clinical perspective.." Diabetes, 2022. https://doi.org/10.1111/dom.14785
RethinkPeptides
RethinkPeptides Research Database. "C-peptide determination in the diagnosis of type of diabetes..." RPEP-06342. Retrieved from https://rethinkpeptides.com/research/maddaloni-2022-cpeptide-determination-in-the
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.